Schwarzenegger has valve replacement by catheter., page-35

Hi Bottle

A little birdy told me that WP might skip the co-development deal altogether and go straight to a co-commercialisation deal. The issue (or lack of) is that a very large portion of the development has been done - for example, animal tests later this year around 3rd quarter.

The dramatic upside will be a much larger than expected co-commercialisation deal as the other party will have bought nothing to the table and when they enter into a bid phase with other big multi-billion $$$ med-tech companies, all vying for the right to co-commercialise the AHZ TAVR.

I'm guessing they all know that whoever partners has a chance to dominate that $3B market CAGR ~20%

Suckii's numbers aren't looking exponential enough imo )))

DYOR and GLTAH